Prosecution Insights
Last updated: October 26, 2026

Gillian Chelsea Reglas, USPTO Patent Examiner

Listed by the USPTO as REGLAS, GILLIAN CHELSEA

Tech Center 1600 • Art Units: 1632

This examiner grants 32% of resolved cases

Analysis

REGLAS, GILLIAN CHELSEA is assigned to tech center 1600 and art unit 1632. The record contains 65 resolved cases, a 32.3% allowance rate, and a median of 1447 days to allowance. The interview lift is 37.5%, showing a meaningful association between interviews and improved allowance outcomes in this record.

The leading companies are StemSight Oy, Massachusetts Institute of Technology, and Ucl Business Ltd. The principal firms are Knobbe, Martens, Olson & Bear, LLP, WOLF GREENFIELD & SACKS, P.C., and Baker Botts L.L.P. The small resolved-case base calls for caution in generalizing, but it supports including interviews in application-specific planning. The 1447-day median indicates that counsel should address long prosecution timelines early, including the timing of amendments and continuation filings.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

32.3%
Allow Rate
-27.7% vs TC avg
116
Total Applications
+37.5%
Interview Lift
1447
Avg Prosecution Days
Based on 65 resolved cases, 2023–2026

Rejection Statute Breakdown

5.8%
§101 Eligibility
14.7%
§102 Novelty
40.5%
§103 Obviousness
31.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18924564 SCALABLE FABRICATION OF A SELF-ASSEMBLED CELL SHEET AND USES THEREOF Non-Final OA McMaster University
18310048 COMPOSITIONS AND METHODS FOR CELLULAR COMPONENT TRANSFER THERAPY Non-Final OA The Johns Hopkins University
17419234 SYNTHETIC MOLECULAR FEEDBACK CIRCUITS AND METHODS OF USING THE SAME Final Rejection The Regents of the University of California
18012959 METHOD FOR PREPARING COMPOSITION FOR CULTURING PANCREATIC ORGANOIDS, COMPOSITION THEREFOR, AND METHOD FOR CULTURING ORGANOIDS BY USING SAME Non-Final OA POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION
17435943 CULTURE MEDIUM FOR MAMMALIAN EXPANDED POTENTIAL STEM CELLS, COMPOSITION, AND METHODS THEREOF Non-Final OA THE UNIVERSITY OF HONG KONG
17251587 USE OF FIBROBLASTS AND/OR MODIFIED FIBROBLASTS FOR THREE DIMENSIONAL TISSUE PRINTING Non-Final OA Figene, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Gillian Chelsea Reglas's allowance rate?

32.3% of resolved applications examined by Gillian Chelsea Reglas were allowed (65 resolved cases), compared with 38.1% across Art Unit 1632 over the last five years.

Does an interview help with examiner Gillian Chelsea Reglas?

This examiner's interview lift is +37.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Gillian Chelsea Reglas take to allow a patent?

Applications allowed by Gillian Chelsea Reglas took 1,447 days on average from filing to allowance.

Which art unit does examiner Gillian Chelsea Reglas work in?

Gillian Chelsea Reglas examines applications in Art Unit 1632 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month